These immune evasion mechanisms include the loss of MHC class I molecule expression on the surface of tumor cells by downmodulating antigen processing and the presentation of peptide antigens on MHC molecules, thereby directly preventing recognition by CD8+ T cells [7,8,9]. This evidence concerns the gene CD8A and neoplasm.